Device Week, April 26, 2019 – Paragonix Launches Cardiac Organ Transport Device; Boston Scientific Becomes Third US TAVR Rival
In this edition of Device Week, Medtech Insight's Reed Miller chats with Marion Webb about her Start-Up Spotlight feature on Paragonix Technologies, which hopes to replace conventional organ transportation with its newly launched SherpaPak system. Reed Miller discusses the impact of Boston Scientific's entry into the US TAVR market after the US FDA approved its Lotus Edge TAVR system.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode: